Cost watchdog ICER dubs most MS drugs 'overpriced,' giving only Sanofi's Lemtrada a pass
admin 7th March 2017 Uncategorised 0 Cost watchdog ICER dubs most MS drugs ‘overpriced,’ giving only Sanofi’s Lemtrada a pass
chelfand
Tue, 03/07/2017 – 11:19
More: Cost watchdog ICER dubs most MS drugs 'overpriced,' giving only Sanofi's Lemtrada a pass
Source: fierce